Cholesteryl Ester Transfer Protein Penetrates Lipoproteins for Cholesteryl Ester Transfer

Gang Ren,Shengli Zhang,Giorgio Cavigiolio,Dongsheng Lei,Michael Oda,Karl H. Weisgraber,Kerry-Anne Rye,Henry J. Pownall,Xiayang Qiu
DOI: https://doi.org/10.1016/j.bpj.2009.12.212
IF: 3.4
2010-01-01
Biophysical Journal
Abstract:Human cholesteryl ester transfer protein (CETP), a hydrophobic glycoprotein (476 amino acids, ∼74 kDa), mediates the transfer of cholesteryl ester (CE) from high-density lipoproteins (HDL) to apo-B containing lipoproteins (low-density lipoproteins - LDL; very low density lipoproteins - VLDL). The crystal structure of CETP reveals a banana-shaped protein consisting of N- and C-terminal β-barrel domains, a central β-sheet, and a ∼60-Å-long hydrophobic cavity. Since CETP deficiency is associated with elevated 'good-cholesterol' (HDL-associated) levels via delayed catabolism, as a result, CETP has become a high interest pharmacological drug target. Here, we investigated the mechanism of CETP-mediated neutral lipid transfer by electron microscopy (EM), image-processing, and molecular dynamic simulations (MDS). We discovered that: 1) CETP bridges HDL and LDL/VLDL to form a ternary complex; 2) the CETP C-terminal beta-barrel domain penetrates partially into the LDL/VLDL surface; 3) the N-terminal beta-barrel domain penetrates through the HDL surface and interacts with the CE core; and 4) MDS analysis suggested that the penetrating regions of CETP are highly mobile and form pores that connect to cavities running through the central axis of the CETP molecule to generate a tunnel. The tunnel was mainly hydrophobic and connected the distal ends through its central cavities. Thus, we proposed CETP resembles a Chinese finger trap, in which both beta-barrel domains penetrate the lipoprotein surface, resulting in pressure from both ends. The pressure may result in the anti-twisting of the two domains, leading to opening of the tunnel for CE transfer between HDL and LDL. The distal end of N-terminal beta-barrel domain could be particularly important for the design of pharmacological inhibitors, as blockage of the N-terminal beta-barrel domain would prevent CE transfer with a low probability of off target effects on normal HDL metabolism.
What problem does this paper attempt to address?